These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 26046454)

  • 1. Human group3 innate lymphoid cells express DR3 and respond to TL1A with enhanced IL-22 production and IL-2-dependent proliferation.
    Ahn YO; Weeres MA; Neulen ML; Choi J; Kang SH; Heo DS; Bergerson R; Blazar BR; Miller JS; Verneris MR
    Eur J Immunol; 2015 Aug; 45(8):2335-42. PubMed ID: 26046454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of the TL1A/DR3 Axis in the Activation of Group 2 Innate Lymphoid Cells in Subjects with Eosinophilic Asthma.
    Machida K; Aw M; Salter BMA; Ju X; Mukherjee M; Gauvreau GM; O'Byrne PM; Nair P; Sehmi R
    Am J Respir Crit Care Med; 2020 Oct; 202(8):1105-1114. PubMed ID: 32584596
    [No Abstract]   [Full Text] [Related]  

  • 3. The TNF-family ligand TL1A and its receptor DR3 promote T cell-mediated allergic immunopathology by enhancing differentiation and pathogenicity of IL-9-producing T cells.
    Richard AC; Tan C; Hawley ET; Gomez-Rodriguez J; Goswami R; Yang XP; Cruz AC; Penumetcha P; Hayes ET; Pelletier M; Gabay O; Walsh M; Ferdinand JR; Keane-Myers A; Choi Y; O'Shea JJ; Al-Shamkhani A; Kaplan MH; Gery I; Siegel RM; Meylan F
    J Immunol; 2015 Apr; 194(8):3567-82. PubMed ID: 25786692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naive and activated T cells display differential responsiveness to TL1A that affects Th17 generation, maintenance, and proliferation.
    Jones GW; Stumhofer JS; Foster T; Twohig JP; Hertzog P; Topley N; Williams AS; Hunter CA; Jenkins BJ; Wang EC; Jones SA
    FASEB J; 2011 Jan; 25(1):409-19. PubMed ID: 20826539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A major population of mucosal memory CD4+ T cells, coexpressing IL-18Rα and DR3, display innate lymphocyte functionality.
    Holmkvist P; Roepstorff K; Uronen-Hansson H; Sandén C; Gudjonsson S; Patschan O; Grip O; Marsal J; Schmidtchen A; Hornum L; Erjefält JS; Håkansson K; Agace WW
    Mucosal Immunol; 2015 May; 8(3):545-58. PubMed ID: 25269704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of DR3 signaling causes loss of ILC3s and exacerbates intestinal inflammation.
    Li J; Shi W; Sun H; Ji Y; Chen Y; Guo X; Sheng H; Shu J; Zhou L; Cai T; Qiu J
    Nat Commun; 2019 Jul; 10(1):3371. PubMed ID: 31358760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TL1A and DR3, a TNF family ligand-receptor pair that promotes lymphocyte costimulation, mucosal hyperplasia, and autoimmune inflammation.
    Meylan F; Richard AC; Siegel RM
    Immunol Rev; 2011 Nov; 244(1):188-96. PubMed ID: 22017439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor Necrosis Factor-like Cytokine TL1A and Its Receptors DR3 and DcR3: Important New Factors in Mucosal Homeostasis and Inflammation.
    Siakavellas SI; Bamias G
    Inflamm Bowel Dis; 2015 Oct; 21(10):2441-52. PubMed ID: 26099067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of TL1A and its receptor DR3 in two models of chronic murine ileitis.
    Bamias G; Mishina M; Nyce M; Ross WG; Kollias G; Rivera-Nieves J; Pizarro TT; Cominelli F
    Proc Natl Acad Sci U S A; 2006 May; 103(22):8441-6. PubMed ID: 16698931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of the DR3-TL1A Axis in Donor Mice Leads to Regulatory T Cell Expansion and Activation With Reduction in Graft-Versus-Host Disease.
    Mavers M; Simonetta F; Nishikii H; Ribado JV; Maas-Bauer K; Alvarez M; Hirai T; Turkoz M; Baker J; Negrin RS
    Front Immunol; 2019; 10():1624. PubMed ID: 31379829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TL1A (TNFSF15) and DR3 (TNFRSF25): A Co-stimulatory System of Cytokines With Diverse Functions in Gut Mucosal Immunity.
    Valatas V; Kolios G; Bamias G
    Front Immunol; 2019; 10():583. PubMed ID: 30972074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The TL1A-DR3 Axis Selectively Drives Effector Functions in Human MAIT Cells.
    Sattler A; Thiel LG; Ruhm AH; Souidi N; Seifert M; Herberth G; Kotsch K
    J Immunol; 2019 Dec; 203(11):2970-2978. PubMed ID: 31628153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microbiota-Induced TNF-like Ligand 1A Drives Group 3 Innate Lymphoid Cell-Mediated Barrier Protection and Intestinal T Cell Activation during Colitis.
    Castellanos JG; Woo V; Viladomiu M; Putzel G; Lima S; Diehl GE; Marderstein AR; Gandara J; Perez AR; Withers DR; Targan SR; Shih DQ; Scherl EJ; Longman RS
    Immunity; 2018 Dec; 49(6):1077-1089.e5. PubMed ID: 30552020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dominant role for TL1A/DR3 pathway in IL-12 plus IL-18-induced IFN-gamma production by peripheral blood and mucosal CCR9+ T lymphocytes.
    Papadakis KA; Zhu D; Prehn JL; Landers C; Avanesyan A; Lafkas G; Targan SR
    J Immunol; 2005 Apr; 174(8):4985-90. PubMed ID: 15814728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TL1A increased the differentiation of peripheral Th17 in rheumatoid arthritis.
    Zhou M; Liu R; Su D; Feng X; Li X
    Cytokine; 2014 Sep; 69(1):125-30. PubMed ID: 24832108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The tumor necrosis factor-like cytokine 1A/death receptor 3 cytokine system in intestinal inflammation.
    Bamias G; Jia LG; Cominelli F
    Curr Opin Gastroenterol; 2013 Nov; 29(6):597-602. PubMed ID: 24100723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Commensal and Pathogenic Bacteria Indirectly Induce IL-22 but Not IFNγ Production From Human Colonic ILC3s via Multiple Mechanisms.
    Castleman MJ; Dillon SM; Purba CM; Cogswell AC; Kibbie JJ; McCarter MD; Santiago ML; Barker E; Wilson CC
    Front Immunol; 2019; 10():649. PubMed ID: 30984202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of TL1A in the pathogenesis of rheumatoid arthritis.
    Zhang J; Wang X; Fahmi H; Wojcik S; Fikes J; Yu Y; Wu J; Luo H
    J Immunol; 2009 Oct; 183(8):5350-7. PubMed ID: 19786547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The TNF-family cytokine TL1A inhibits proliferation of human activated B cells.
    Cavallini C; Lovato O; Bertolaso A; Pacelli L; Zoratti E; Zanolin E; Krampera M; Zamò A; Tecchio C; Cassatella MA; Pizzolo G; Scupoli MT
    PLoS One; 2013; 8(4):e60136. PubMed ID: 23565196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TNF superfamily member TL1A elicits type 2 innate lymphoid cells at mucosal barriers.
    Yu X; Pappu R; Ramirez-Carrozzi V; Ota N; Caplazi P; Zhang J; Yan D; Xu M; Lee WP; Grogan JL
    Mucosal Immunol; 2014 May; 7(3):730-40. PubMed ID: 24220298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.